Agios Pharmaceuticals | AGIO - 負債





負債 変化する 日付
AbbVie USD 1000K 70.48B 2025-09
Agios Pharmaceuticals USD 44.52M 4.24M 2025-09
Alnylam Pharmaceuticals USD 1.31B 11.39M 2025-09
Amgen USD 54.59B 1.62B 2025-09
Arrowhead Research USD 366.28M 13.25M 2025-09
Astellas Pharma JPY 831.43B 83.94B 2025-03
AstraZeneca USD 32.63B 207M 2025-09
Bayer EUR 39.39B 1.31B 2025-03
Biogen USD 6.29B 1.7M 2025-12
BioMarin Pharmaceutical USD 604.24M 375K 2025-09
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Daiichi Sankyo JPY 201.14B 99.81B 2025-09
Eli Lilly USD 42.51B 2.6B 2025-09
Exelixis USD 176.46M 3.38M 2025-09
Gilead Sciences USD 24.94B 5M 2025-12
GlaxoSmithKline GBP 17.75B 396M 2025-09
Incyte USD 40.41M 855K 2025-12
Ionis Pharmaceuticals USD 2.33B 1.1B 2025-12
Merck USD 41.37B 5.97B 2025-09
Moderna USD 734M 7M 2025-09
Nektar Therapeutics USD 0 0 2022-06
Novartis USD 32.64B 1.37B 2025-06
Novartis USD 32.02B 615M 2025-09
Pfizer USD 60.85B 78M 2025-09
Puma Biotechnology USD 89.06M 55.07M 2024-06
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Roche Holding CHF 33.03B 1.41B 2025-06
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09